| 查看: 3197 | 回复: 33 | |||
| 【有奖交流】积极回复本帖子,参与交流,就有机会分得作者 chun_yan 的 77 个金币 ,回帖就立即获得 1 个金币,每人有 1 次机会 | |||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | |||
[交流]
俄乌冲突,殃及池鱼(大家遇到过我这种倒霉情况吗?)
|
|||
|
四年前我的课题与俄罗斯的团队进行了合作,2021年3月第一次投稿,被拒,补了一年多实验,2022年5月重新投稿,送审。经过三轮审稿,现在编辑说由于俄乌战争,不允许俄罗斯科研人员所在单位出现在文章里,可能以个人名义发表,但是具体怎么裁定到现在也没下来,已经等了快俩月了。。 俄罗斯团队为我们做出了重要结果,不让其带上单位发表论文显然不合适,但现在撤稿也不划算。杂志那边也是逗,第一次投稿时俄乌战争没有开始,而第二次从投稿到审稿阶段,竟从来没提过这事,结果现在给我整这出。。 还有,看谁今后还说科学无国界 ![]() 附上主编的回复 -------------------------------------------------------------------------------------- Subject: RE: Re:TPC2023-RA-00200DR1 Receipt of revised MS by The Plant Cell. Dear Dr. Li, I sincerely apologize for the lengthy delay in our response. The issue is an unusual one: a discussion within the society (ASPB) about how to handle manuscripts with Russian Institutions as affiliations. Since the start of the dreadful, unprovoked, and cruel war on Ukraine, there have been discussions and debates about what to do with these papers, which are relatively few. While in no way comparable to the humanitarian disaster that Russia has caused, Ukrainian science has been decimated, and the scientists and their families are in terrible situations, along with their countrymen. While we are of course reluctant to penalize our Russian colleagues and authors – for as individuals, they are often friends and collaborators – but allowing Russian institutions to go about their business as if nothing has happened hardly seems appropriate. It’s slightly analogous to the situation in sports, including the Olympics, in which Russian athletes have faced unusual circumstances for the same reasons (plus the history of doping). In that case, the international decision was to allow individuals to compete, but not representing the institution of Russian national athletics, and instead as unaffiliated athletes. I referred your manuscript to the ASPB’s “Publications Committee” for their input. They have been slow to reach a decision. I will follow up with them. We know that you originally submitted before Russia attacked Ukraine, and that the paper went through one or two other decision points after the invasion, and the institutional affiliations weren’t noticed at that time. Again, my apologies for the complexity of the situation, and that your paper was caught up in this. |
» 猜你喜欢
申博
已经有7人回复
征友后感触
已经有9人回复
食品与机械 编辑C处理稿子时间
已经有4人回复
27年药学 考博申请
已经有6人回复
注意啦!用基金购买打印纸、硒鼓、优盘、移动硬盘、个人计算机属于违规了
已经有4人回复
为了不被淘汰,必须要开始第三次奋斗了
已经有12人回复
IVD领域内综述投稿推荐
已经有5人回复
» 抢金币啦!回帖就可以得到:
中山大学(深圳)陈友课题组招收2027年学术型博士
+1/186
广州征女友
+2/128
吉林大学-招收2027级-能源电池-博士研究生
+1/87
求助 国军标一篇 GJB3206B-2022 技术状态管理
+1/41
双一流大学湘潭大学“化工过程模拟与强化”国家地方联合工程研究中心招收博士生
+1/32
吉大-苏大联合培养,2027年考核制博士
+1/31
华东师大先进材料课题组招收考核制博士生1名——能源、材料等方向
+1/30
华东师大先进材料课题组招收考核制博士生1名——能源、材料等方向
+1/26
云南大学有机化学专业有机合成 生物探针等方向均可 招聘博士生一名
+1/17
寻求负极焦气流磨代加工
+1/13
武汉双一流高校干细胞与肿瘤生物学团队招聘2027级申请考核制博士生
+1/12
福建师范大学多孔框架团队2027年博士招生!!
+1/10
地学的资源里显示“指定的主题已经归档,禁止浏览”是怎么回事?
+1/10
天津理工大学国家杰青鲁统部团队
+1/9
南京工业大学柔性电子(未来技术)学院招2027申请考核制博士生(钙钛矿太阳能方向)
+1/8
【试剂分享】告别微流控:预制 Mal-LN29-tLNP 抗体偶联试剂盒,脾脏 CD8+ 转染 97.2%
+1/5
2026 Virtual Cell Challenge揭晓:胜出的为何是“实测迁移+统计校准+细胞生成”
+1/3
加巴喷丁有关物质研究难点浅析,杂质对照品可提供全套表征
+2/2
北京工商大学中国轻工业聚合物发泡材料加工与应用重点实验室2026年博士研究生招生
+1/2
北京工商大学中国轻工业聚合物发泡材料加工与应用重点实验室2026年博士研究生招生
+1/2
21楼2023-07-31 10:55:15
chenhuanlong
禁虫 (文学泰斗)
★
chun_yan(金币+1): 谢谢参与
chun_yan(金币+1): 谢谢参与
|
本帖内容被屏蔽 |
4楼2023-07-29 21:34:39
7楼2023-07-30 01:58:53
★
chun_yan(金币+1): 谢谢参与
chun_yan(金币+1): 谢谢参与
|
本帖内容被屏蔽 |
11楼2023-07-30 09:31:45
简单回复
jiaoxg10楼
2023-07-30 08:55
回复
chun_yan(金币+1): 谢谢参与




yuekong3楼
2023-07-29 20:53
回复
tzynew2楼
2023-07-29 20:46
回复
chun_yan(金币+1): 谢谢参与
i 发自小木虫Android客户端
2023-07-29 22:01
回复
甄士隐2075楼
2023-07-29 21:40
回复
我才是肖牧冲12楼
2023-07-30 11:09
回复
chun_yan(金币+1): 谢谢参与
。 发自小木虫Android客户端
sdlclqt9楼
2023-07-30 07:22
回复
chun_yan(金币+1): 谢谢参与
唉 发自小木虫Android客户端











回复此楼